BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10521382)

  • 1. Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen.
    Pernerstorfer T; Stohlawetz P; Hollenstein U; Dzirlo L; Eichler HG; Kapiotis S; Jilma B; Speiser W
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2517-23. PubMed ID: 10521382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen J; Knechtelsdorfer M; Stohlawetz P; Graninger W; Eichler HG; Speiser W; Jilma B
    Circulation; 1999 Dec 21-28; 100(25):2485-90. PubMed ID: 10604885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humans.
    Hollenstein U; Homoncik M; Knöbl P; Pernerstorfer T; Graggaber J; Eichler HG; Handler S; Jilma B
    Clin Pharmacol Ther; 2002 May; 71(5):368-74. PubMed ID: 12011822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration.
    Kjalke M; Oliver JA; Monroe DM; Hoffman M; Ezban M; Hedner U; Roberts HR
    Thromb Haemost; 1997 Oct; 78(4):1202-8. PubMed ID: 9364985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lepirudin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen JB; Stohlawetz P; Eichler HG; Handler S; Speiser W; Jilma B
    Blood; 2000 Mar; 95(5):1729-34. PubMed ID: 10688831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of lipopolysaccharide-induced tissue factor expression in monocytes by urinary trypsin inhibitor in vitro and in vivo.
    Molor-Erdene P; Okajima K; Isobe H; Uchiba M; Harada N; Shimozawa N; Okabe H
    Thromb Haemost; 2005 Jul; 94(1):136-45. PubMed ID: 16113797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein.
    Boden G; Vaidyula V; Homko C; Mozzoli M; Rao AK
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1333-9. PubMed ID: 17213471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock.
    Edgington TS; Mackman N; Fan ST; Ruf W
    Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S15-27. PubMed ID: 1364116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
    Spona J; Feichtinger W; Kindermann C; Schneider B; Mellinger U; Walter F; Moore C; Gräser T
    Contraception; 1997 Aug; 56(2):67-75. PubMed ID: 9315414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the kinetic constants of tissue factor/factor VII/factor VIIA and antithrombin/heparin using surface plasmon resonance.
    Björquist P; Boström S
    Thromb Res; 1997 Feb; 85(3):225-36. PubMed ID: 9058497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
    Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procoagulant human monocytes mediate tissue factor/factor VIIa-dependent platelet-thrombus formation when exposed to flowing nonanticoagulated human blood.
    Barstad RM; Hamers MJ; Kierulf P; Westvik AB; Sakariassen KS
    Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):11-6. PubMed ID: 7749805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia.
    Rijneveld AW; Weijer S; Bresser P; Florquin S; Vlasuk GP; Rote WE; Spek CA; Reitsma PH; van der Zee JS; Levi M; van der Poll T
    Crit Care Med; 2006 Jun; 34(6):1725-30. PubMed ID: 16625114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy between tissue factor activity and tissue factor expression in endotoxin-induced monocytes is associated with apoptosis and necrosis.
    Henriksson CE; Klingenberg O; Ovstebø R; Joø GB; Westvik AB; Kierulf P
    Thromb Haemost; 2005 Dec; 94(6):1236-44. PubMed ID: 16411400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation system and platelets are fully activated in uncomplicated sepsis.
    Mavrommatis AC; Theodoridis T; Orfanidou A; Roussos C; Christopoulou-Kokkinou V; Zakynthinos S
    Crit Care Med; 2000 Feb; 28(2):451-7. PubMed ID: 10708182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protamine inhibits tissue factor-initiated extrinsic coagulation.
    Chu AJ; Wang ZG; Raicu M; Beydoun S; Ramos N
    Br J Haematol; 2001 Nov; 115(2):392-9. PubMed ID: 11703341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the pan-selectin antagonist bimosiamose (TBC1269) in experimental human endotoxemia.
    Mayr FB; Firbas C; Leitner JM; Spiel AO; Reiter RA; Beyer D; Meyer M; Wolff G; Jilma B
    Shock; 2008 Apr; 29(4):475-82. PubMed ID: 18598003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IV. Anticoagulant activity of compound 48/80: inhibition of factor VII activation in leukemia THP-1 monocytes.
    Chu AJ; Wang ZG; Raphael UO
    J Cardiovasc Pharmacol; 2000 Nov; 36(5):649-55. PubMed ID: 11065226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia.
    Derhaschnig U; Reiter R; Knöbl P; Baumgartner M; Keen P; Jilma B
    Blood; 2003 Sep; 102(6):2093-8. PubMed ID: 12750166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.